title: Glucose tolerance in HIV-1 treated patients who switched from boosted-protease inhibitors to etravirine.
authors.affiliation: aInfectious Diseases Department, San Raffaele Scientific Institute bUniversity Vita-Salute San Raffaele, Milan, Italy.
authors.forename: Alessia
authors.initials: A
authors.lastname: Carbone
authors.forename: Alba
authors.initials: A
authors.lastname: Bigoloni
authors.forename: Laura
authors.initials: L
authors.lastname: Galli
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Spagnuolo
authors.forename: Nicola
authors.initials: N
authors.lastname: Gianotti
authors.forename: Adriano
authors.initials: A
authors.lastname: Lazzarin
authors.forename: Antonella
authors.initials: A
authors.lastname: Castagna
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005951:Glucose Tolerance Test; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000302:isolation & purification; D006801:Humans; D008297:Male; D008875:Middle Aged; D009570:Nitriles; D011446:Prospective Studies; D011480:Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D011724:Pyridazines / Q000009:adverse effects / Q000627:therapeutic use*; D011743:Pyrimidines
chemical_list: D019380:Anti-HIV Agents; D009570:Nitriles; D011480:Protease Inhibitors; D011724:Pyridazines; D011743:Pyrimidines; C451734:etravirine